A validated model of disease progression in IgA nephropathy

Giovanni Gambaro, Riccardo Magistroni, Luciana Furci, Marco Leonelli, Mario Masellis, Giulia Ligabue, Leonardo Lucchi, Antonio Lupo, Brigida Brezzi, Luca Manganelli, Giada Pedrazzi, Marco Ricardi, Luisa Bormioli, Alberto Albertazzi

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

IgA nephropathy (IgAN) is the most common primary glomerulonephritis in the general population. There is accumulating evidence that immunosuppressive treatment is efficacious in IgAN. However, it is critical to define appropriate indicators for this therapy especially in the wake of potentially deleterious side effects to immunosuppressives.
Original languageEnglish
Pages (from-to)32-40
Number of pages9
JournalJN. JOURNAL OF NEPHROLOGY
Volume19
Publication statusPublished - 2006

Keywords

  • Adolescent
  • Adult
  • Biopsy
  • Disease Progression
  • Female
  • Follow-Up Studies
  • Glomerulonephritis, IGA
  • Humans
  • Immunosuppressive Agents
  • Italy
  • Male
  • Prognosis
  • Retrospective Studies
  • Survival Rate

Fingerprint

Dive into the research topics of 'A validated model of disease progression in IgA nephropathy'. Together they form a unique fingerprint.

Cite this